# Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients

> **NCT02970877** · PHASE2 · COMPLETED · sponsor: **Johane Allard** · enrollment: 29 (actual)

## Conditions studied

- Obesity, Morbid
- Insulin Resistance

## Interventions

- **BIOLOGICAL:** Fecal filtrate from 150 g stool from healthy lean donors
- **BIOLOGICAL:** Fecal filtrate from 150 g of the recipient's own stool

## Key facts

- **NCT ID:** NCT02970877
- **Lead sponsor:** Johane Allard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02970877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02970877, "Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02970877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*